Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L Jocoy

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Bioinformatics Advances|April 28, 2023
ACDA: implementation of an augmented drug synergy prediction algorithmSergii Domanskyi, Emily L Jocoy, Anuj Srivastava, et al.
The European Journal of Neuroscience|January 23, 2010
Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoidsVéronique M André, Carlos Cepeda, Damian M Cummings, et al.
Disease Models & Mechanisms|March 27, 2023
The Mouse Models of Human Cancer database (MMHCdb)Dale A Begley, Debra M Krupke, John P Sundberg, et al.
Frontiers in Systems Neuroscience|May 28, 2011
Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatumEmily L Jocoy, Véronique M André, Damian M Cummings, et al.
Bioinformatics (Oxford, England)|November 26, 2024
STRprofiler: efficient comparisons of short tandem repeat profiles for biomedical model authenticationJared M Andrews, Michael W Lloyd, Steven B Neuhauser, et al.
Experimental Hematology|February 6, 2024
In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenograftsJoanna Randall, Kathryn Evans, Ben Watts, et al.
Pediatric Blood & Cancer|June 20, 2023
In vivo activity of the dual SYK/FLT3 inhibitor TAK-659 against pediatric acute lymphoblastic leukemia xenograftsKeira Hughes, Kathryn Evans, Eric J Earley, et al.
Journal of Neuroscience Research|April 22, 2003
Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasiaCarlos Cepeda, Raymond S Hurst, Jorge Flores-Hernández, et al.
International Journal of Molecular Sciences|February 13, 2026
Targeting Pediatric Glioblastomas by Combining OLIG2 Inhibitor CT-179 with Fractionated Radiation in a Panel of Patient-Derived Orthotopic Xenograft Mouse ModelsHolly Lindsay, Yuchen Du, Lin Qi, et al.
Hemasphere|January 20, 2025
The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemiaBen Watts, Christopher M Smith, Kathryn Evans, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Bioinformatics Advances|April 28, 2023
ACDA: implementation of an augmented drug synergy prediction algorithmSergii Domanskyi, Emily L Jocoy, Anuj Srivastava, et al.
The European Journal of Neuroscience|January 23, 2010
Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoidsVéronique M André, Carlos Cepeda, Damian M Cummings, et al.
Disease Models & Mechanisms|March 27, 2023
The Mouse Models of Human Cancer database (MMHCdb)Dale A Begley, Debra M Krupke, John P Sundberg, et al.
Frontiers in Systems Neuroscience|May 28, 2011
Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatumEmily L Jocoy, Véronique M André, Damian M Cummings, et al.
Bioinformatics (Oxford, England)|November 26, 2024
STRprofiler: efficient comparisons of short tandem repeat profiles for biomedical model authenticationJared M Andrews, Michael W Lloyd, Steven B Neuhauser, et al.
Experimental Hematology|February 6, 2024
In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenograftsJoanna Randall, Kathryn Evans, Ben Watts, et al.
Pediatric Blood & Cancer|June 20, 2023
In vivo activity of the dual SYK/FLT3 inhibitor TAK-659 against pediatric acute lymphoblastic leukemia xenograftsKeira Hughes, Kathryn Evans, Eric J Earley, et al.
Journal of Neuroscience Research|April 22, 2003
Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasiaCarlos Cepeda, Raymond S Hurst, Jorge Flores-Hernández, et al.
International Journal of Molecular Sciences|February 13, 2026
Targeting Pediatric Glioblastomas by Combining OLIG2 Inhibitor CT-179 with Fractionated Radiation in a Panel of Patient-Derived Orthotopic Xenograft Mouse ModelsHolly Lindsay, Yuchen Du, Lin Qi, et al.
Hemasphere|January 20, 2025
The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemiaBen Watts, Christopher M Smith, Kathryn Evans, et al.
Pageof 2